Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 8-K Event Results of operations
  2. 4 Open-market sale Chief Operating Officer sold 2,488 shares at $17.45 ($43,418)
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 8-K Event Executive or director change
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Financial Officer sold 7,402 shares at $21.55 ($159,513)
  11. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
  12. 4 Open-market sale Chief Financial Officer sold 46,144 shares at an average $19.95 ($920,736)
  13. 4 Derivatives Options or other derivatives
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Open-market sale Chief Operating Officer sold 2,500 shares at $17.94 ($44,852)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 47 · 923 filings